retatrutide triple agonist glp-1 gip glucagon ly3437943 LY3437943, a novel GIP, GLP-1, and receptor in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial Tirzepatide = 2 #Retatrutide =
Pay in 4 interest-free payments of $5.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 24 - Nov 29










/assets/images/provider/photos/2805921.jpeg)

















